About: Thrombolysis with alteplase 3-4.5 h after acute ischaemic stroke (SITS-ISTR): an observational study

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Thrombolysis with alteplase 3-4.5 h after acute ischaemic stroke (SITS-ISTR): an observational study Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 12 September 2008

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) article scientifique publié en 2008 (fr) наукова стаття, опублікована у вересні 2008 (uk) 2008 թվականի սեպտեմբերի 12-ին հրատարակված գիտական հոդված (hy) scientific article published on 12 September 2008 (en) artículu científicu espublizáu en setiembre de 2008 (ast)
publication date	wds:Q81963102-D33B135E-CB0C-4FEE-B5BD-C20B675B24B8
publication date	2008-09-12 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q81963102-E5DC4BF3-5FFB-48B6-A00D-BECC22EA6A1D
language of work or name	English
cites work	wds:Q81963102-0650AD95-B93E-4F66-811C-001D9EC80064 wds:Q81963102-0E0A5DFB-4A2A-4C7D-A9BF-14327166C43A wds:Q81963102-243AF4CC-96AE-4D08-B1D6-195B75F59F8D wds:Q81963102-45D089D7-B0EE-4DA7-808F-255891E15835 wds:Q81963102-47EC23C7-D2FE-42BF-B4DC-09390F4A6030 wds:Q81963102-531224BC-29F0-4D92-B035-FF9B07D461C9 wds:Q81963102-578909A3-DFE0-412D-9703-2BD961D334D5 wds:Q81963102-705F376A-80C7-4C60-A2AE-D0FB111F7E70 wds:Q81963102-8661A8B0-35D5-48C5-B336-B7EC3EE0A55C wds:Q81963102-99E71471-D0A5-4C37-AD7B-70A746F2AFE1 wds:Q81963102-9C0ABAA5-87A7-4A68-B19A-B8F63EE4471F wds:Q81963102-9E415E11-FD2C-418E-920F-86E03DB24450 wds:Q81963102-C8B1696B-3861-4AAF-8E44-73865782DDDC wds:Q81963102-CE3B59F5-8166-4581-A787-BA34AB1889BD wds:Q81963102-E1B32D23-6878-41D6-8806-9BCFF0FDCAA6 wds:Q81963102-E8356C85-C92E-4529-91F3-4182213A2710 wds:Q81963102-F2E3929F-94AC-4178-80D3-1A88733335E9 wds:Q81963102-F9F591CE-A8AD-49E8-BBFE-9676948B61A1
cites work	Tissue plasminogen activator for acute ischemic stroke Guidelines for the Early Management of Adults With Ischemic Stroke Multivariable analysis of outcome predictors and adjustment of main outcome results to baseline data profile in randomized controlled trials: Safe Implementation of Thrombolysis in Stroke-MOnitoring STudy (SITS-MOST). Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS) Guidelines for Management of Ischaemic Stroke and Transient Ischaemic Attack 2008 Interobserver agreement for the assessment of handicap in stroke patients. Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European-Australasian Acute Stroke Study (ECASS II) Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment Two-sided confidence intervals for the single proportion: comparison of seven methods MRI-based and CT-based thrombolytic therapy in acute stroke within and beyond established time windows: an analysis of 1210 patients. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. The rtPA (alteplase) 0- to 6-hour acute stroke trial, part A (A0276g) : results of a double-blind, placebo-controlled, multicenter study. Thromblytic therapy in acute ischemic stroke study investigators Thrombolytic therapy with recombinant tissue plasminogen activator for acute ischemic stroke: where do we go from here? A cumulative meta-analysis Measurements of acute cerebral infarction: a clinical examination scale Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke Safety of routine IV thrombolysis between 3 and 4.5 h after ischemic stroke.
author name string	wds:Q81963102-1CDD5B63-DB10-4091-B093-B13412778C71 wds:Q81963102-7074D8F2-B7D7-4002-9E96-3306B759676D wds:Q81963102-BF0ED3BD-3E6D-4B0C-8358-D7802A6B6C89 wds:Q81963102-CD66939B-D632-4E59-8120-BDD332F48CD0 wds:Q81963102-E26C04F9-34E8-497C-8E5E-CB7A3D56D3F1 wds:Q81963102-E71082F6-A278-4852-805E-1A970CA0953B wds:Q81963102-E93F5B1F-B5C5-443B-8EBE-184E0B40AE22 wds:Q81963102-EB700746-7305-4E06-9AAF-682771FA2603
author name string	Danilo Toni Werner Hacke Antoni Dávalos Kennedy R Lees Mónica Millán Nils Wahlgren Risto O Roine SITS investigators
rdfs:label	Thrombolysis with alteplase 3-4.5 h after acute ischaemic stroke (SITS-ISTR): an observational study (en) Thrombolysis with alteplase 3-4.5 h after acute ischaemic stroke (SITS-ISTR): an observational study (nl)
skos:prefLabel	Thrombolysis with alteplase 3-4.5 h after acute ischaemic stroke (SITS-ISTR): an observational study (en) Thrombolysis with alteplase 3-4.5 h after acute ischaemic stroke (SITS-ISTR): an observational study (nl)
name	Thrombolysis with alteplase 3-4.5 h after acute ischaemic stroke (SITS-ISTR): an observational study (en) Thrombolysis with alteplase 3-4.5 h after acute ischaemic stroke (SITS-ISTR): an observational study (nl)
author	wds:Q81963102-341BE14C-8E72-40FE-AB20-4B628CA8CD34 wds:Q81963102-9A20E9A3-367E-43FD-ADDB-1EC146B131B7
author	Keith Muir Niaz Ahmed
title	wds:Q81963102-1142D912-F3C3-4CDF-BE54-1E4326BFEFEE
title	Thrombolysis with alteplase 3-4.5 h after acute ischaemic stroke (SITS-ISTR): an observational study (en)
page(s)	wds:Q81963102-472FB414-591B-4E9A-9AA6-075FCD1C244E
page(s)	1303-1309
instance of	wds:Q81963102-564F4A21-7468-4AF1-88CE-85DC25AA46F5
instance of	scholarly article
main subject	wds:Q81963102-DEB81409-58A0-48C7-89D6-09F0E4782F27
main subject	thrombolysis
PubMed ID	wds:Q81963102-095BEF5B-FB6E-480F-A0A0-11FB2E8B3295
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/18790527
PubMed ID	18790527
published in	wds:Q81963102-10623E74-9AD7-4FCC-B752-97706E4FAC6F
published in	The Lancet
issue	wds:Q81963102-830FC178-A33B-491B-891E-446238B103C3
volume	wds:Q81963102-D70F3375-C76F-4D4B-945F-167C1DB32BEA
issue	9646
volume	372
DOI	wds:Q81963102-B39197A9-C924-461F-A2C2-7FD49FAA2AF1
DOI	http://dx.doi.org/10.1016/S0140-6736(08)61339-2
DOI	10.1016/S0140-6736(08)61339-2
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q81963102
is cites work of	Stroke treatment with alteplase given 3.0-4.5 h after onset of acute ischaemic stroke (ECASS III): additional outcomes and subgroup analysis of a randomised controlled trial. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials Hyperacute management of ischemic stroke Future trials of endovascular mechanical recanalisation therapy in acute ischemic stroke patients: a position paper endorsed by ESMINT and ESNR : part I: Current situation and major research questions Impact of tissue plasminogen activator on the neurovascular unit: from clinical data to experimental evidence Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: a science advisory from the American Heart Association/American Stroke Association.

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 196 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software